ZA202210422B - Formula of probiotics and metabolites thereof for relieving metabolic syndrome, and use thereof - Google Patents

Formula of probiotics and metabolites thereof for relieving metabolic syndrome, and use thereof

Info

Publication number
ZA202210422B
ZA202210422B ZA2022/10422A ZA202210422A ZA202210422B ZA 202210422 B ZA202210422 B ZA 202210422B ZA 2022/10422 A ZA2022/10422 A ZA 2022/10422A ZA 202210422 A ZA202210422 A ZA 202210422A ZA 202210422 B ZA202210422 B ZA 202210422B
Authority
ZA
South Africa
Prior art keywords
probiotics
metabolites
formula
metabolic syndrome
relieving
Prior art date
Application number
ZA2022/10422A
Inventor
Liwei Xie
Original Assignee
Inst Of Microbiology Guangdong Academy Of Sciences Guangdong Detection Center Of Microbiology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Of Microbiology Guangdong Academy Of Sciences Guangdong Detection Center Of Microbiology filed Critical Inst Of Microbiology Guangdong Academy Of Sciences Guangdong Detection Center Of Microbiology
Publication of ZA202210422B publication Critical patent/ZA202210422B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/113—Acidophilus
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/145—Gasseri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/173—Reuteri
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/51—Bifidobacterium
    • A23V2400/531—Lactis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A61K2035/115—Probiotics
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/225—Lactobacillus
    • C12R2001/23—Lactobacillus acidophilus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA2022/10422A 2022-04-15 2022-09-20 Formula of probiotics and metabolites thereof for relieving metabolic syndrome, and use thereof ZA202210422B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202210392976.2A CN114480228A (en) 2022-04-15 2022-04-15 Probiotics for relieving metabolic syndrome, metabolite formula and application thereof

Publications (1)

Publication Number Publication Date
ZA202210422B true ZA202210422B (en) 2022-10-26

Family

ID=81489607

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/10422A ZA202210422B (en) 2022-04-15 2022-09-20 Formula of probiotics and metabolites thereof for relieving metabolic syndrome, and use thereof

Country Status (4)

Country Link
CN (1) CN114480228A (en)
NL (1) NL2033398B1 (en)
WO (1) WO2023040426A1 (en)
ZA (1) ZA202210422B (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117100773A (en) * 2023-10-25 2023-11-24 山东威曼宠物食品有限公司 Lactobacillus plantarum King07 metazoan preparation and application thereof

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114984058A (en) * 2022-04-15 2022-09-02 广东省科学院微生物研究所(广东省微生物分析检测中心) Application of probiotic and metabolite (metazoan) formula thereof in preparation of product for relieving colorectal inflammation
CN114480228A (en) * 2022-04-15 2022-05-13 广东省科学院微生物研究所(广东省微生物分析检测中心) Probiotics for relieving metabolic syndrome, metabolite formula and application thereof
CN116159082A (en) * 2023-02-27 2023-05-26 山东中科嘉亿生物工程有限公司 Product for preventing and/or treating obesity and metabolic syndrome, and preparation method and application thereof
CN116509906B (en) * 2023-03-23 2024-04-02 浙江大学 Application of lactobacillus reuteri ZJ617 in improving non-alcoholic fatty liver disease and fat accumulation
CN116814503B (en) * 2023-07-27 2024-01-30 山东奈思健康科技有限责任公司 Post-production meta-product for promoting calcium supplement and bone protection as well as preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2532062A1 (en) * 2005-01-14 2006-07-14 Nutrinor Cooperative Agro-Alimentaire Du Saguenay Lac St-Jean Food composition for maintaining and restoring digestive functions
US9717767B2 (en) * 2014-05-12 2017-08-01 BiOWiSH Technologies, Inc. Compositions and methods for improving human health and nutrition
CN107518411A (en) * 2017-01-13 2017-12-29 江苏西宏生物医药有限公司 A kind of anti-diarrhea enteral nutrition composition
CN109998113A (en) * 2019-04-18 2019-07-12 广东省微生物研究所（广东省微生物分析检测中心） A kind of functional food of the probiotics preparation with effect of lowering blood sugar
WO2021156777A1 (en) * 2020-02-06 2021-08-12 Buzzelet Development And Technologies Ltd. Microbial combinations and uses thereof
CN114984058A (en) * 2022-04-15 2022-09-02 广东省科学院微生物研究所(广东省微生物分析检测中心) Application of probiotic and metabolite (metazoan) formula thereof in preparation of product for relieving colorectal inflammation
CN114480228A (en) * 2022-04-15 2022-05-13 广东省科学院微生物研究所(广东省微生物分析检测中心) Probiotics for relieving metabolic syndrome, metabolite formula and application thereof

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117100773A (en) * 2023-10-25 2023-11-24 山东威曼宠物食品有限公司 Lactobacillus plantarum King07 metazoan preparation and application thereof
CN117100773B (en) * 2023-10-25 2024-02-09 山东威曼宠物食品有限公司 Lactobacillus plantarum King07 metazoan preparation and application thereof

Also Published As

Publication number Publication date
CN114480228A (en) 2022-05-13
WO2023040426A1 (en) 2023-03-23
NL2033398B1 (en) 2023-11-06

Similar Documents

Publication Publication Date Title
ZA202210422B (en) Formula of probiotics and metabolites thereof for relieving metabolic syndrome, and use thereof
EP3981122A4 (en) Wireless devices and systems including examples of mismatch correction scheme
SG10201907552TA (en) An active substance of lactobacillus paracasei gks6, a composition comprising thereof and its use for promoting longevity
EP3938369A4 (en) Tyk2 inhibitors and uses thereof
EP4036941A4 (en) Planar transformer and active circuit
EP3833373A4 (en) Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
EP4073071A4 (en) Use and pharmaceutical composition of phenylisoxazolyl methylene-naphthalene-ether derivatives
EP3782988A4 (en) Crystal form of 3-(4-methyl-1h-imidazol-1-yl)-5-trifluoromethylaniline monohydrochloride and use thereof
IL289786A (en) Cannabinoid derivatives as pharmaceutically active compounds and methods of preparation thereof
EP4223759A4 (en) Pyrazolopyridazinone compound, and pharmaceutical composition and use thereof
EP3914251A4 (en) N-(phenylsulfonyl)benzamides and related compounds as bcl-2 inhibitors
IL277913A (en) Topical formulations comprising strontium and methylsulfonylmethane (msm) and niethods of treatment
EP3790529B8 (en) Formulations containing active oxygen compounds and devices for application thereof
EP3778555A4 (en) Novel compound and pharmaceutical composition for preventing or treating obesity or metabolic syndrome comprising same
EP3806865A4 (en) Modified tetracycline for treatment of alcohol use disorder, pain and other disorders involving potential inflammatory processes
IL290927A (en) Composition used for combating metabolic diseases and uses of composition
EP4043440A4 (en) Substituted nitrogen heterocyclic compound and anesthetic effect thereof
EP4098649A4 (en) Alpha-hydroxylated fatty-acid metabolites, medical uses of same and use as biomarkers
EP4038062A4 (en) N-(1h-imidazol-2-yl)benzamide compound and pharmaceutical composition comprising the same as active ingredient
EP3915974A4 (en) Diamine compound, and polyimide precursor and polyimide film using same
EP4069196C0 (en) Eye topical composition containing metabolites of the fermentation of lactobacillus
NO2022013I1 (en) Finerenone and its salts, solvates and solvates of the salts thereof
GB202304604D0 (en) New compounds and medical uses thereof
GB202304595D0 (en) New compounds and medical uses thereof
EP4029515A4 (en) Anti-infection effects of hnrnpa2b1 and use thereof